ReviewCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2025
Stent Fracture of Biolimus-Eluting Stent (Biofreedom) Complicated With Micro-Coronary Artery Aneurysm.
Review in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A review of the pathogenic mechanism and clinical management progress of in-stent calcification restenosis.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Coronary stent fractures (SFs) are an emerging complication of coronary stents. There are numerous risk factors for SF, which include vessel angulation, use of sirolimus-eluting stent (SES), long stents, multiple stent layers, stent overlap, inflammation, hypersensitivity, stenting in the right coronary artery, heavy calcification, ostial bifurcational lesions, and stent overexpansion. There have been reports of SF in BES (Nobori) in past studies, but no reports on BES (Biofreedom) have been documented yet. SF increases the risk of in-stent restenosis, stent thrombosis (ST), target lesion revascularization and major adverse cardiac events. A coronary artery aneurysm (CAA) is a rare complication of SF. Although the risk of CAA rupture with SF is high, the treatment and management of CAA with SF remain unclear. Here, we report the case of a 72-year-old man who had SF of a BES (Biofreedom) complicated with a micro-CAA and review some of the literature.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.